Université de Montréal
Mary Lordkipanidze is working as assistant professor.
Expertise are: Thrombosis and hemostasis,Platelet function tests,Personalized Therapy,Cardiovascular illnesses
Smith CW, Thomas SG, Raslan Z, Patel P, Byrne M, Lordkipanidzé M, Bem D, Meyaard L, Senis YA, Watson SP, Mazharian A. Mice Lacking the Inhibitory Collagen Receptor LAIR-1 Exhibit a Mild Thrombocytosis and Hyperactive Platelets. Arteriosclerosis, thrombosis, and vascular biology. 2017 Jan 1:ATVBAHA-117.
Messas N, Tanguay JF, Lordkipanidzé M. Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial. Journal of thoracic disease. 2017 May;9(5):E440.
Landry S, Tanguay JF, Lordkipanidzé M. Personalizing antiplatelet therapies: What have we learned from recent trials?. Platelets. 2017 Jun 19:1-9.